CN Patent
CN109206487B — 改良的特拉万星或其盐的制备方法
Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2022-04-12 · 4y expired
What this patent protects
本发明属于药物合成领域,具体而言涉及一种改良的特拉万星或其盐的制备方法。该制备方法调整曼尼希反应投料顺序,控制反应温度,大大缩短反应时间,并使双‑曼尼希副产物的含量明显降低。另外,通过低沸点溶剂进行后处理得到的中间体化合物III,易于工业操作,纯度达到95%以上。
USPTO Abstract
本发明属于药物合成领域,具体而言涉及一种改良的特拉万星或其盐的制备方法。该制备方法调整曼尼希反应投料顺序,控制反应温度,大大缩短反应时间,并使双‑曼尼希副产物的含量明显降低。另外,通过低沸点溶剂进行后处理得到的中间体化合物III,易于工业操作,纯度达到95%以上。
Drugs covered by this patent
- Vibativ (TELAVANCIN HYDROCHLORIDE) · Cumberland
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.